Abstract
The most common therapeutic intervention in medicine is the writing of a prescription. It is especially true in psychiatry as pharmacotherapy has become its mainstay treatment. With over half of the approved drugs having serious adverse effects that were not detected before the approval, it is therefore important to study post-marketing drugs in order to ensure the safety of a drug. The benefits and risks of a psychotropic drug could be studied through using psycho pharmaco epidemiological methods, a science underlying post-marketing drug surveillance. It delineates how psychotropic drugs are prescribed and utilized, investigates reasons underlying prescriptions, and assesses outcomes and variables which may affect these outcomes. This review covers the introduction and development of psycho pharmaco epidemiology, specifically to its scope and limitation, examples of studies published in the past years, and its future perspectives.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
